Narwhal Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$347K Sell
959
-58
-6% -$19.9K 0.02% 140
2026
Q1
$358K Sell
1,017
-97
-9% -$34.6K 0.03% 140
2025
Q4
$365K Sell
1,114
-23
-2% -$7.3K 0.03% 135
2025
Q3
$321K Sell
1,137
-33
-3% -$9.57K 0.02% 141
2025
Q2
$327K Sell
1,170
-3,886
-77% -$1.1M 0.03% 142
2025
Q1
$1.58M Sell
5,056
-26
-0.5% -$7.68K 0.14% 90
2024
Q4
$1.32M Sell
5,082
-45
-0.9% -$13.4K 0.12% 92
2024
Q3
$1.65M Sell
5,127
-20
-0.4% -$6.54K 0.15% 85
2024
Q2
$1.61M Sell
5,147
-47
-0.9% -$13.8K 0.15% 85
2024
Q1
$1.48M Hold
5,194
0.14% 89
2023
Q4
$1.5M Sell
5,194
-257
-5% -$70K 0.16% 88
2023
Q3
$1.47M Sell
5,451
-333
-6% -$83.1K 0.18% 89
2023
Q2
$1.28M Sell
5,784
-92
-2% -$21.3K 0.15% 93
2023
Q1
$1.42M Sell
5,876
-13
-0.2% -$3.19K 0.18% 91
2022
Q4
$1.55M Buy
5,889
+63
+1% +$16.9K 0.21% 87
2022
Q3
$1.31M Buy
5,826
+190
+3% +$46.1K 0.19% 87
2022
Q2
$1.37M Buy
5,636
+839
+17% +$206K 0.19% 83
2022
Q1
$1.16M Sell
4,797
-856
-15% -$197K 0.14% 88
2021
Q4
$1.27M Sell
5,653
-265
-4% -$55.9K 0.14% 86
2021
Q3
$1.26M Sell
5,918
-1,984
-25% -$457K 0.16% 84
2021
Q2
$1.93M Sell
7,902
-1,541
-16% -$379K 0.24% 74
2021
Q1
$2.35M Sell
9,443
-1,085
-10% -$259K 0.32% 68
2020
Q4
$2.42M Buy
10,528
+1,580
+18% +$364K 0.34% 63
2020
Q3
$2.27M Buy
8,948
+860
+11% +$213K 0.37% 63
2020
Q2
$1.91M Buy
8,088
+16
+0.2% +$3.65K 0.33% 65
2020
Q1
$1.64M Buy
8,072
+2,078
+35% +$454K 0.35% 64
2019
Q4
$1.45M Buy
5,994
+56
+0.9% +$12.3K 0.27% 76
2019
Q3
$1.15M Buy
5,938
+1,249
+27% +$240K 0.23% 83
2019
Q2
$864K Buy
4,689
+698
+17% +$125K 0.18% 90
2019
Q1
$758K Hold
3,991
0.16% 97
2018
Q4
$777K Hold
3,991
0.19% 96
2018
Q3
$827K Buy
3,991
+41
+1% +$8.08K 0.18% 101
2018
Q2
$729K Sell
3,950
-3,860
-49% -$683K 0.17% 105
2018
Q1
$1.33M Sell
7,810
-10,950
-58% -$2.01M 0.31% 91
2017
Q4
$3.26M Buy
18,760
+250
+1% +$44.2K 0.75% 46
2017
Q3
$3.45M Sell
18,510
-1,400
-7% -$248K 0.86% 40
2017
Q2
$3.43M Buy
19,910
+50
+0.3% +$8.13K 0.89% 41
2017
Q1
$3.26M Buy
19,860
+1,625
+9% +$270K 0.91% 34
2016
Q4
$2.67M Buy
18,235
+5,640
+45% +$849K 0.8% 41
2016
Q3
$2.1M Hold
12,595
0.66% 52
2016
Q2
$1.92M Buy
12,595
+2,350
+23% +$365K 0.6% 57
2016
Q1
$1.54M Buy
10,245
+250
+3% +$37.1K 0.5% 68
2015
Q4
$1.62M Hold
9,995
0.56% 62
2015
Q3
$1.38M Hold
9,995
0.52% 63
2015
Q2
$1.53M Hold
9,995
0.56% 61
2015
Q1
$1.6M Hold
9,995
0.58% 60
2014
Q4
$1.59M Sell
9,995
-130
-1% -$20.3K 0.62% 62
2014
Q3
$1.42M Hold
10,125
0.57% 65
2014
Q2
$1.2M Sell
10,125
-140
-1% -$16.2K 0.46% 76
2014
Q1
$1.27M Hold
10,265
0.53% 74
2013
Q4
$1.17M Sell
10,265
-1,375
-12% -$156K 0.48% 80
2013
Q3
$1.3M Hold
11,640
0.62% 64
2013
Q2
$1.15M Buy
+11,640
New +$1.21M 0.55% 71

Other funds holding AMGN

Narwhal Capital Management's AMGN Position: Q2 2026 in Review

Narwhal Capital Management reduced its Amgen (AMGN) stake by 5.7% in Q2 2026, selling an estimated $19.9K and leaving 959 shares worth $347K. The position accounts for 0.02% of the portfolio, ranked #140.

Narwhal Capital Management first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.45M in Q3 2017. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Narwhal Capital Management held 959 shares of Amgen worth $347K as of Q2 2026.
  • Narwhal Capital Management sold 58 Amgen shares in Q2 2026, an estimated $19.9K.
  • Amgen made up 0.02% of Narwhal Capital Management's portfolio in Q2 2026, its #140 holding.
  • Narwhal Capital Management first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • Narwhal Capital Management's Amgen position peaked at $3.45M in Q3 2017.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Narwhal Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.